These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 18213631

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A neutralizing anti-fibroblast growth factor 8 monoclonal antibody shows potent antitumor activity against androgen-dependent mouse mammary tumors in vivo.
    Shimada N, Ishii T, Imada T, Takaba K, Sasaki Y, Maruyama-Takahashi K, Maekawa-Tokuda Y, Kusaka H, Akinaga S, Tanaka A, Shitara K.
    Clin Cancer Res; 2005 May 15; 11(10):3897-904. PubMed ID: 15897591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulation of FGF8 expression by the androgen receptor in human prostate cancer.
    Gnanapragasam VJ, Robson CN, Neal DE, Leung HY.
    Oncogene; 2002 Aug 01; 21(33):5069-80. PubMed ID: 12140757
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice.
    Wallner L, Dai J, Escara-Wilke J, Zhang J, Yao Z, Lu Y, Trikha M, Nemeth JA, Zaki MH, Keller ET.
    Cancer Res; 2006 Mar 15; 66(6):3087-95. PubMed ID: 16540658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice.
    Jin RJ, Wang Y, Masumori N, Ishii K, Tsukamoto T, Shappell SB, Hayward SW, Kasper S, Matusik RJ.
    Cancer Res; 2004 Aug 01; 64(15):5489-95. PubMed ID: 15289359
    [Abstract] [Full Text] [Related]

  • 11. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO, Yeon Chun J, Nadiminty N, Trump DL, Ip C, Dong Y, Gao AC.
    Prostate; 2006 Jul 01; 66(10):1070-5. PubMed ID: 16637076
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.
    Mendoza N, Phillips GL, Silva J, Schwall R, Wickramasinghe D.
    Cancer Res; 2002 Oct 01; 62(19):5485-8. PubMed ID: 12359757
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo.
    Dorai T, Cao YC, Dorai B, Buttyan R, Katz AE.
    Prostate; 2001 Jun 01; 47(4):293-303. PubMed ID: 11398177
    [Abstract] [Full Text] [Related]

  • 15. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M.
    Int J Urol; 2007 Mar 01; 14(3):233-9. PubMed ID: 17430262
    [Abstract] [Full Text] [Related]

  • 16. [Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
    Wang YD, Hu Y, Zhang L, Huang J, Sun CY.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct 01; 28(10):659-63. PubMed ID: 18399169
    [Abstract] [Full Text] [Related]

  • 17. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y, Zhong Z, Huber J, Bassi R, Finnerty B, Corcoran E, Li H, Navarro E, Balderes P, Jimenez X, Koo H, Mangalampalli VR, Ludwig DL, Tonra JR, Hicklin DJ.
    Clin Cancer Res; 2006 Nov 01; 12(21):6573-84. PubMed ID: 17085673
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
    Chiu FL, Lin JK.
    Prostate; 2008 Jan 01; 68(1):61-71. PubMed ID: 18008333
    [Abstract] [Full Text] [Related]

  • 19. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
    Day JM, Tutill HJ, Foster PA, Bailey HV, Heaton WB, Sharland CM, Vicker N, Potter BV, Purohit A, Reed MJ.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):251-8. PubMed ID: 18786604
    [Abstract] [Full Text] [Related]

  • 20. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts.
    Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J.
    Clin Cancer Res; 2006 Feb 15; 12(4):1292-8. PubMed ID: 16489086
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.